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Case Presentation

A 53 year old white male with a past medical history significant
for type II diabetes mellitus and orthotopic liver transplant
(December 2006) secondary to hepatitis B cirrhosis presents as
a direct admission to Thomas Jefferson University Hospital in
September 2007 for an orthopedic preoperative risk evaluation.
Patient has had a dull, worsening, non-radiating back pain of six
months duration, beginning after his liver transplant for which
he has been to several outpatient orthopedic physicians. Upon
admission, the patient appeared well, but admitted to a consistent
8/10 back pain that he had been managing at home with narcotic
medications. Of note, outpatient magnetic resonance imaging
(MRI) showed diskitis at L4/L5. Spinal biopsy and cultures
were performed to rule out cord compression, spinal injury and
infection due to his previous surgery and were all negative. On
review of systems, he denied any lower extremity tenderness,
numbness, paresthesias or loss of bowel or bladder function. He
has lost over 70 pounds since his liver transplant. The remainder
of the patient’s past medical history was negative except for a
history of cataracts due to his diabetes mellitus. He reports a
strong family history of hypertension, coronary artery disease
and both type I and type II diabetes mellitus.
On physical examination, the patient was afebrile with stable and
normal vital signs. Cardiovascular exam demonstrated normal
S1 and S2 heart sounds, no murmurs, rubs or gallops, no jugular
venous distention, and no carotid bruits. His lungs were clear
bilaterally without wheezes, rhonchi, or rales. His abdomen did
have a clean, dry and intact Mercedes type scar indicative of his
liver transplantation. The remainder of his physical examination
was within normal limits. Admission labs (Complete Blood
Count, Basic Metabolic Panel, Electrolytes, PT/PTT/INR, Liver
Function Tests), chest X-ray, and EKG were all within normal
limits.
The patient was admitted to the general medical floor to
undergo risk assessment for the laminectomy procedure. As
part his cardiac evaluation, the patient underwent a nuclear
and exercise stress test that showed distal anterior and apical
hypokinesis. Cardiac catheterization was deemed necessary for
further evaluation. Cardiac catheterization demonstrated a 100%
RCA stenosis with significant stenoses in the LAD (70%), LCx
(70%), and OM1 (50%). In light of these findings, the patient’s
orthopedic procedure was delayed until cardiac revascularization could be achieved.

Discussion

This case illustrates a typical example of significant coronary
artery disease (CAD) in an asymptomatic diabetic patient. Type
II diabetes mellitus is a major risk factor for the development of
CAD. Moreover, it is considered a CAD equivalent. Similarly,
CAD is the major cause of morbidity and mortality in people
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with type II diabetes.1 Atherosclerosis occurs earlier, has an
accelerated course, and is more extensive in diabetics compared
with the general population. 22 There are probably several
factors that contribute to this. Type II diabetes is associated
with abnormalities in lipoprotein metabolism and an increased
propensity for oxidative damage; the hyperglycemia of diabetics,
in itself, may accelerate vascular damage; and diabetes is a
hypercoagulable state attributable to enhanced coagulation and
decreased fibrinolysis, as well as platelet hyperaggregability and
endothelial dysfunction.33
The Insulin Resistance Atherosclerosis Study (IRAS) reported
finding considerably greater intima-media thickness in the
common and internal carotid arteries among patients with
established diabetes compared with non-diabetic subjects.44
Diabetic patients without previous myocardial infarctions (MI)
and non-diabetic patients with a previous MI have been found to
have equally high risk for MI. Diabetic patients also have a high
mortality rate from a first MI.55 These observations suggest that
diabetics without obvious CAD may still have extensive atherosclerosis that, if untreated, could lead to serious cardiovascular
complications. Some have suggested that this provides a rationale
for assessing and treating cardiovascular risk factors in diabetic
patients with the same aggressive approaches recommended for
non-diabetic patients with a prior MI.
Diabetes treatment protocols (diet, exercise, pharmacological
agents, and insulin) concentrate on controlling glycemia which
leads to CAD. However, glycemia is not as strongly associated
with macrovascular disease as it is with microvascular disease.
Macrovascular disease appears to result from dyslipidemia in
the diabetic patient. The form of dyslipidemia most frequently
observed in diabetics is characterized by increased triglyceride
levels and decreased high density lipoprotein (HDL) cholesterol
levels. Diabetics also tend to have a higher level of smaller,
denser low density lipoprotein (LDL) subclass pattern B than
non-diabetics due to increases in hepatic triglyceride lipase.66
Several studies have provided evidence of the link between
diabetic dyslipidemia and CAD.77 In diabetic patients who had
CAD events during a 7-year follow-up period had higher levels
of total triglycerides, LDL, triglycerides, and VLDL cholesterol,
and lower levels of HDL and HDL2 cholesterol than diabetic
patients who did not have such events. Other studies have found
that both high levels of apolipoprotein B (apoB) and small, dense
LDL among patients with high apoB levels also predict coronary
artery disease.
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